Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
ImmuPharma ( (GB:IMM) ) has shared an update.
Immupharma PLC, a UK-based pharmaceutical company, has reported a change in its major shareholdings. Lanstead Capital Investors LP has reduced its stake in the company from 9.99% to 6.90%. This reduction in voting rights could potentially impact Immupharma’s shareholder dynamics and influence its future strategic decisions.
More about ImmuPharma
YTD Price Performance: -29.99%
Average Trading Volume: 1,288,133
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.86M
See more data about IMM stock on TipRanks’ Stock Analysis page.
